ANL

NASD Adlai Nortye Group Ltd. Sponsored ADR Class A
Oct 22, 2026 · 7:18 AM ET EOD Market Closed

$11.26 ↑ +0.00 (+0.00%) Trading Up from the previous close of $11.26, $0.42 below the day’s high of $11.68

YTD change
+692.96%
vs 20-day SMA
-19.77%
vs 200-day SMA
+2.07%

Price ranges

Previous day
$10.80 $11.68
open $10.80 close $11.26
+$0.46 (+4.26%)
Today
$10.80 $11.68
$11.26
Past week
$10.34 $12.46
from $11.76 now $11.26
-$0.50 (-4.21%)
Past month
$10.34 $16.95
from $16.60 now $11.26
-$5.34 (-32.17%)
This year
$1.32 $17.25
from $1.42 now $11.26
+$9.84 (+692.96%)

Price & Performance

-4.87 (-30.19%) / 6M

$8.61$11.47$14.33$17.19Apr 22Jul 23Oct 21

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 41.7% away from all-time highs of $19.30
  • ANL is up 693% since the beginning of the year
  • ANL is up 580% over the past 12 months
  • ANL is down 32% over the past 1 month
  • 32% of all ANL investors are betting against ANL

ANL reads neutral: price sits above one of the two key moving averages, the 12-month move is +582.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.035
Earnings momentum +333.3% Quarterly EPS growth
Quarterly change +333.3%

Valuation

P/E ratio N/A
Enterprise value $302.0M
Beta 1.16

Balance sheet & scale

IncomeN/A
Revenue$18.1M
Cash$232.9M
Debt$26.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $725.1M

Adlai Nortye Group Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $438.34 -0.14%
MRNA Moderna, Inc. $245.81 +1.54%
RVMD Revolution Medicines, Inc. $194.28 -1.15%
ROIV Roivant Sciences Ltd. $36.80 +5.38%
BNTX BioNTech SE Sponsored ADR $91.29 +0.13%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.